ELUTE

About:

Elute is a developer of polymer-controlled drug delivery devices design to prevent and treat orthopedic and other surgical bone infections.

Website: http://elutinc.com

Description:

Elute develops polymer-controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections. ElutiBone, its lead product candidate, claims to significantly improve patient outcomes and transform the management of peri-prosthetic bone infections. It is supposed to have delivered an initial burst of tobramycin directly to the infected site at a concentration high enough to treat the infection without compromising bone growth.

Total Funding Amount:

$1.64M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)elutinc.com

Founders:

Dennis Farrar

Number of Employees:

1-10

Last Funding Date:

2016-03-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai